Plain-English translation of NCT06711822 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a device called ShockPulse-10 that uses shock waves to help break up calcium deposits in hardened heart arteries. The device is used during a procedure where a stent (a small wire mesh tube) is placed in the artery to keep it open. Researchers want to see if this treatment is safe and effective for patients with significant calcium buildup in their coronary arteries.
Calcium deposits in heart arteries can make it very difficult to place stents properly and can reduce how well the stent works. This trial is testing whether the shock wave device can safely remove or break up these calcified deposits, making the stent placement procedure more effective.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive the ShockPulse-10 procedure as part of your stent placement during a heart catheterization. The medical team will use shock waves to help clear calcium from your artery before placing the stent. After the procedure, you will be followed for 6 months with visits to check how well the treatment worked and to monitor for any complications.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
China
Sponsor
Keya Medical
Enrollment target
~205 participants
Started
July 2024
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
XIANTAO SONG, Dortor
Beijing Anzhen Hosipital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.